This site is for customers in Japan. Customers in other regions, please go to Global page.
HOME > Product search results > Code No. CY-8150 CircuLex PCSK9-LDLR in vitro Binding Assay Kit

Code No. CY-8150

CircuLex PCSK9-LDLR in vitro Binding Assay Kit

Price

¥98,000

Availability (in Japan)

10 or more

(In Japan at 01:30,
Nov 18, 2017 in JST)

Size

96 assays

Components Microplate, Recombinant His-tagged PCSK9 wild type, Biotinylated anti-His-tag monoclonal antibody, Reaction Buffer, HRP-conjugated Streptavidin, Conjugate Dilution Buffer, 10X Wash Buffer, Substrate Reagent, Stop Solution
Intended use This Kit is primarily designed to screening inhibitors of PCSK9-LDLR interaction in vitro.
Storage temp. 4°C Manufacturer MBL
Related products CY-8078 CircuLex Mouse/Rat PCSK9 ELISA Kit
CY-8079 CircuLex Human PCSK9 ELISA Kit
CY-8152 CircuLex PCSK9-cIAP1 in vitro Binding Assay Kit
CY-R2310 PCSK9 Wild Type in culture medium
CY-R2311 PCSK9 D374Y in culture medium
CY-R2320 PCSK9 Wild Type/Δ53 in culture medium
CY-R2321 CircuLex PCSK9 D374Y/Δ53 in culture medium
CY-R2330 PCSK9 Wild Type (Human)
CY-R2331 PCSK9 D374Y
CY-R2333 PCSK9 R194A
CY-R2340 LDLR EGF-AB domain
CY-R2341 LDLR EGF-AB domain, Myc-tagged
CY-R2342 LDLR EGF-AB domain H306Y
CY-R2343 LDLR EGF-AB domain H306Y, Myc-tagged
CY-8112 CircuLex Human STAP1 ELISA Kit
CY-8153 CircuLex Human PCSK9 Functional Assay Kit
Citations
  1. Lammi C et al. Lupin peptides modulate the protein-protein interaction of PCSK9 with the low density lipoprotein receptor in HepG2 cells. Sci Rep. 6, 29931 (2016)(PMID:27424515 )
Product category
Research area
Metabolism
Drug discovery
この製品に関するお問い合わせをする

  • The availability is based on the information in Japan at 01:30, Nov 18, 2017 in JST.
  • The special price is shown in red color.
  • Please note that products cannot be ordered from this website. To purchase the items listed in this website, please contact us or local distributers.
  • For storage temparature: RT: room temparature
  • Please note that products in this website might be changed or discontinued without notification in advance for quality improvement.